Combination of oral idarubicin and prednimustine in advanced breast cancer: a phase II study-Reference-Cited by-同舟云学术

Combination of oral idarubicin and prednimustine in advanced breast cancer: a phase II study

Published:1997-02 Issue:2 Volume:33 Page:312-315
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Barnadas A.,Mendiola C.,Casado A.,Villar A.,Jimeno J.,Clerigue M.,Rosell R.,Diaz-rubio E.,Cortés-funes H.,De Paredes M.Garcia

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference15 articles.

1. Idarubicin. A review of its pharmacodynamic and pharmacokinetics properties, and therapeutic potential in the chemotherapy of cancer;Hollingshead;Drugs,1991

2. Idarubicin: an anthracycline antineoplastic agent;Cersomino;Clin Pharrn,1992

3. Antitumor antibiotics and related compounds;Riggs,1992

4. Potential role of oral anthracyclines in older patients with cancer;Lasota;Drugs Aging,1994

5. Comparative phase II study of idarubicin versus doxorubicin in advanced breast cancer;Martoni;Oncology,1990

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RB1 and p53 at the crossroad of EMT and triple negative breast cancer;CELL CYCLE;2011

2. Anticancer oral therapy: Emerging related issues;Cancer Treatment Reviews;2010-12

3. Effective oral chemotherapy for breast cancer: pillars of strength;Annals of Oncology;2008-02

4. A Pharmacokinetic Study of Idarubicin in Japanese Patients With Malignant Lymphoma: Relationship With Leukocytopenia and Neutropenia;International Journal of Hematology;2001-10

5. Multicenter Phase II Study of Oral Idarubicin in Treated and Untreated Patients with B-Chronic Lymphocytic Leukemia;Leukemia & Lymphoma;2000-01